A defect in IL-10 production was first identified in patients with MS [12], [13], [14], followed by a report of defective IL-10 production in patients with asthma [15] and altered cytokine production was shown in patients with rheumatoid arthritis [11]. This evidence concerns the gene IL10 and myeloid sarcoma.